Deflazacort is a glucocorticoid belonging to the acetonides or O-isopropylidene derivative class. It is widely used as an anti-inflammatory and immunosuppressive agent in the treatment of a variety of conditions, including autoimmune disorders and allergic reactions. Patented in 1969, Deflazacort has been a key medication for managing chronic inflammation.
Parent: Deflazacort
The synthesis and storage of Deflazacort can result in the presence of related compounds and impurities that must be monitored to ensure safety and efficacy.
Advanced techniques like High-Performance Liquid Chromatography (HPLC) and Gas Chromatography-Mass Spectrometry (GC-MS) are used to detect and quantify these impurities.
Avoid taking Deflazacort with NSAIDs like ibuprofen, as they can increase the risk of gastrointestinal ulcers. Additionally, inform your doctor if you are taking antifungal medications, antibiotics, or other steroids, as these can interact with Deflazacort.
Prolonged use of Deflazacort can lead to side effects such as weight gain, increased blood sugar levels, weakened bones (osteoporosis), and suppression of the immune system, which can increase the risk of infections.
While Deflazacort is generally safe, long-term or high-dose use can strain the kidneys, especially in individuals with preexisting kidney conditions. Regular monitoring is advised during extended use.
The duration of Deflazacort treatment depends on the condition being treated. It is usually prescribed for short-term use; however, for chronic conditions, long-term therapy may be required under close medical supervision to monitor potential side effects.
